Position in COLL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,252,887
+$1,606,714 QoQ
Shares Held
200,356
+17.3% QoQ
Ownership
0.615%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 280 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $156,689,854 across 37 Drug Manufacturers - Specialty & Generic names. COLL ranks #9 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
178,605 | $30,102,086 | |
| 2 | ZTS |
Zoetis Inc.
|
200,280 | $14,392,120 | |
| 3 | VTRS |
Viatris Inc
|
849,694 | $13,493,139 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
262,336 | $10,763,646 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
424,167 | $10,438,749 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
216,865 | $10,251,208 | |
| 7 | LQDA |
Liquidia Corp
|
122,836 | $9,793,714 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
16,798 | $9,101,659 |
All Filings in COLL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,252,887 | 200,356 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,646,173 | 170,734 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,495,835 | 75,504 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,598,133 | 45,674 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $993,965 | 33,614 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $949,050 | 31,794 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $955,019 | 33,334 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,302,205 | 33,701 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,144,000 | 35,528 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,440,571 | 37,109 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,159,451 | 37,669 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,029,396 | 46,058 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,072,415 | 49,903 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $791,286 | 32,984 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $781,468 | 33,684 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $553,314 | 34,539 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $613,891 | 34,644 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $731,209 | 35,914 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $679,279 | 36,364 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $769,090 | 38,961 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $929,903 | 39,336 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $966,628 | 40,786 | Shares | Defined | 2021-05-12 | |
| 2020-03-31 | $356,451 | 21,828 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||